Samil Pharmaceutical Co.,Ltd (000520.KS)
KRW 13130.0
(-3.95%)
KRW 13130.0
(-3.95%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 116.16 KRW | 5822.17% |
| 2022 | -2.03 KRW | 99.47% |
| 2021 | -386.63 KRW | -487.79% |
| 2020 | 99.70 KRW | 70.28% |
| 2019 | 58.55 KRW | 107.95% |
| 2018 | -736.85 KRW | -575.95% |
| 2017 | -109.01 KRW | -242.63% |
| 2016 | 76.43 KRW | 51.32% |
| 2015 | 50.51 KRW | 105.29% |
| 2014 | -954.48 KRW | -242.87% |
| 2013 | 668.09 KRW | 373.56% |
| 2012 | -244.22 KRW | 57.24% |
| 2011 | -571.11 KRW | -433.38% |
| 2010 | 171.31 KRW | -70.16% |
| 2009 | 574.10 KRW | 311.01% |
| 2008 | 139.68 KRW | -68.42% |
| 2007 | 442.32 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 21.19 KRW | 117.79% |
| 2024 Q1 | -118.07 KRW | -290.99% |
| 2023 FY | - KRW | 5822.17% |
| 2023 Q4 | 61.82 KRW | 234.04% |
| 2023 Q2 | 50.48 KRW | -7.56% |
| 2023 Q1 | 54.61 KRW | -57.49% |
| 2023 Q3 | -46.12 KRW | -191.36% |
| 2022 Q4 | 128.47 KRW | 193.15% |
| 2022 FY | - KRW | 99.47% |
| 2022 Q2 | -19.68 KRW | -180.16% |
| 2022 Q3 | -137.92 KRW | -600.81% |
| 2022 Q1 | 24.55 KRW | 109.93% |
| 2021 Q2 | -83.77 KRW | -476.16% |
| 2021 Q3 | -120.21 KRW | -43.5% |
| 2021 Q1 | 22.27 KRW | 149.72% |
| 2021 FY | - KRW | -487.79% |
| 2021 Q4 | -247.21 KRW | -105.65% |
| 2020 Q3 | -17.73 KRW | -250.0% |
| 2020 FY | - KRW | 70.28% |
| 2020 Q1 | 135.00 KRW | 274.28% |
| 2020 Q2 | 11.82 KRW | -91.24% |
| 2020 Q4 | -44.79 KRW | -152.62% |
| 2019 Q3 | -33.18 KRW | -144.24% |
| 2019 Q4 | -77.46 KRW | -133.45% |
| 2019 Q2 | 75.00 KRW | -14.06% |
| 2019 Q1 | 87.27 KRW | 132.54% |
| 2019 FY | - KRW | 107.95% |
| 2018 Q3 | -209.55 KRW | -12.72% |
| 2018 FY | - KRW | -575.95% |
| 2018 Q4 | -268.22 KRW | -28.0% |
| 2018 Q2 | -185.91 KRW | -132.56% |
| 2018 Q1 | -79.94 KRW | -303.25% |
| 2017 FY | - KRW | -242.63% |
| 2017 Q3 | -172.62 KRW | -614.49% |
| 2017 Q4 | 39.33 KRW | 122.78% |
| 2017 Q2 | -24.16 KRW | -146.61% |
| 2017 Q1 | 51.83 KRW | 120.93% |
| 2016 Q1 | 46.56 KRW | 247.9% |
| 2016 Q4 | 23.46 KRW | -16.54% |
| 2016 FY | - KRW | 51.32% |
| 2016 Q3 | 28.11 KRW | 242.19% |
| 2016 Q2 | -19.77 KRW | -142.46% |
| 2015 Q1 | 49.63 KRW | 113.43% |
| 2015 Q4 | -31.48 KRW | -323.9% |
| 2015 Q3 | 14.06 KRW | -11.07% |
| 2015 Q2 | 15.81 KRW | -68.14% |
| 2015 FY | - KRW | 105.29% |
| 2014 Q3 | -260.03 KRW | 19.67% |
| 2014 Q4 | -369.56 KRW | -42.12% |
| 2014 FY | - KRW | -242.87% |
| 2014 Q1 | -36.46 KRW | -104.67% |
| 2014 Q2 | -323.72 KRW | -787.88% |
| 2013 Q4 | 781.37 KRW | 1731.93% |
| 2013 Q1 | 25.92 KRW | 117.96% |
| 2013 Q2 | -19.77 KRW | -176.27% |
| 2013 FY | - KRW | 373.56% |
| 2013 Q3 | -47.88 KRW | -142.19% |
| 2012 Q3 | 11.86 KRW | 141.54% |
| 2012 Q4 | -144.31 KRW | -1316.78% |
| 2012 FY | - KRW | 57.24% |
| 2012 Q1 | 48.32 KRW | 104.91% |
| 2012 Q2 | -28.55 KRW | -159.09% |
| 2011 Q4 | -984.00 KRW | -1124.95% |
| 2011 FY | - KRW | -433.38% |
| 2011 Q3 | -80.33 KRW | 33.3% |
| 2011 Q2 | -120.43 KRW | -156.76% |
| 2011 Q1 | 212.16 KRW | 177.12% |
| 2010 FY | - KRW | -70.16% |
| 2010 Q3 | -35.14 KRW | -130.89% |
| 2010 Q4 | 76.56 KRW | 317.87% |
| 2010 Q2 | 113.76 KRW | 388.66% |
| 2010 Q1 | 23.28 KRW | 113.91% |
| 2009 Q4 | -167.37 KRW | -118.38% |
| 2009 Q1 | -52.27 KRW | 80.34% |
| 2009 Q3 | 910.56 KRW | 788.72% |
| 2009 Q2 | -132.21 KRW | -152.94% |
| 2009 FY | - KRW | 311.01% |
| 2008 Q1 | 280.24 KRW | 210.27% |
| 2008 Q3 | -55.35 KRW | -135.6% |
| 2008 FY | - KRW | -68.42% |
| 2008 Q2 | 155.49 KRW | -44.52% |
| 2008 Q4 | -265.88 KRW | -380.36% |
| 2007 Q1 | 278.24 KRW | 0.0% |
| 2007 Q2 | 210.40 KRW | -24.38% |
| 2007 Q3 | 139.32 KRW | -33.78% |
| 2007 FY | - KRW | 0.0% |
| 2007 Q4 | -254.13 KRW | -282.41% |